chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tightness in my chest; fatigue; chills; headache; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration administered in left arm at a workplace clinic facility on 17Feb2021 12:45 (Batch/Lot Number: EL3247) (at the age of 62-year-old) as DOSE 2, SINGLE for covid-19 immunization. The patient was not pregnant at the time of vaccination. No other vaccine in four weeks. The patient had no covid prior to vaccination and was not covid tested post vaccination. Medical history included high cholesterol and attention deficit hyperactivity disorder (ADD), both controlled by medication. The patient also has a sensitivity to erythromycin but not an allergy. Concomitant medications included atorvastatin (LIPITOR [ATORVASTATIN]); amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); and unspecified vitamins. Historical vaccine includes first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), administered in left arm on 27Jan2021 12:45 PM (Batch/Lot Number: EL3247) (at the age of 61-year-old) for covid-19 immunisation. On 17Feb2021 at 04:00 PM, the patient reported that she has a tightness in her chest that has continued over the last 8 days and since the date of the second shot. The symptom was not severe but, different from how she has ever felt. Otherwise, she had the regular reaction of fatigue, chills and headache but those symptoms only lasted 24 hours. The events resulted in doctor or other healthcare professional office/clinic visit. There was no treatment for the events. The patient also confirmed that she reported the symptoms on February 25th but, she did have symptoms starting the evening of February 17th. She was delayed in reporting because the symptoms are not severe and her main concern was how long the symptoms have lasted. The final outcome of the events was not yet recovered.  No follow-up attempts are possible. No further information is expected.
Headache, Fever (up to 101.5) starting morning after shot and continuing until 2nd day after shot, Sweating, Shivers, Body aches, Joint Pain  Duration of all symptoms: approx 40 hours
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old male patient received BNT162b2 (BNT162B2), on 12Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 76 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Cysts on kidneys" (unspecified if ongoing); "elevated liver enzymes" (unspecified if ongoing); "stroke 7 years ago" (unspecified if ongoing). Concomitant medication(s) included: STATIN [ATORVASTATIN CALCIUM], stop date: 17May2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt developed headache, nausea, blurred vision, dizziness and fever of 102-103 F (taken orally) within 12 hours of receiving Varivax, Adacel and Menactra. Mom also reported swelling and redness of right arm (site of Menactra) along with pains which lasted 24 hrs.
25 minutes after receiving shot: migraine 35 minutes after: hard to breathe. Tight and restricted chest. Neck pain.  7 hours after shot: diaphragm hurt. Couldn?t feel hungry or full.   Symptoms went away about 48 hours after receiving the shot, with the exception of fatigue, that lasted 4 days.
Got the FLU shot and 1 week later got the FLU; Initial information was received on 29-Dec-2021 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown demographics patient who had experienced an event got the flu shot and 1 week later got the flu while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, dose, route, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious event "got the flu shot and 1 week later got the flu" (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. It was reported "Got the Flu shot and 1 week later got the Flu, but it wasn't hard on like it was few years ago"  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Got the FLU shot and 1 week later got the FLU).  At time of reporting, the outcome was Unknown for the event got the flu shot and 1 week later got the flu.
Pt w/out s/s associated with Covid. Pt in hospital w/other concerns. Pt +Covid PCR while in hospital.
This case was reported by a healthcare professional and described the occurrence of malaise in a 78-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent medications included Lorazepam, Baby aspirin, CIPRO, Atenolol, Vitamin D, COUMADIN, COZAAR and CRESTOR. It was reported that the patient has a history of atrial fibrillation, osteoporosis and hyperkalemia. On 15 September 2010 at 16:30 the subject received a dose of FLULAVAL at 0.5 ml in the left arm. An unspecified amount of time after vaccination with FLULAVAL, the subject experienced malaise, fatigue and sore throat. The events were resolved at the time of reporting. Malaise was reported to be unrelated to treatment with FLULAVAL. Attribution for fatigue and sore throat was not known.
patient felt light headed and dizzy 5 minutes after receiving Menactra vaccine. Patient was assisted to the bed to lay down, given OJ,  cold pack and crackers. VS were taken and were stable. Patient was able to walk out facility with mother within 10 minutes after event took place.
Dull, ongoing pain at site of injection; occasionally wakes me up if sleeping on left arm (injected arm), sore to the touch.
HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
Information has been received from a registered nurse, concerning a 12 year old female patient, who in May 2007, was vaccinated with a dose of Gardasil. Two days after the vaccination, the patient had a "breakthrough menstrual period;" the patient's LMP was 2 weeks prior to the vaccination. The nurse clarified, this was not 'spotting," but rather a "normal flow period," and confirmed that the patient had not experienced anything similar prior to the vaccination. The patient sought unspecified medical attention. No further information is available.
soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness on her arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029e028a) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced MYALGIA (soreness on her arm). At the time of the report, MYALGIA (soreness on her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pt is brought in by her mom for a rash. She got her 15 month immunizations two days ago, she started to get a rash yesterday. She had some blistering last night where her bandaid was on the bandaid part. Then she started to have some urticarial rash that is extending down her legs around her trunk and in the axillae. It has been itching her some. She has been a little more clingy, but overall she has been okay. She has also noticed some swelling of her joints and occasionally refuses to walk and occasionally has a little limp, but not always. She otherwise has had no fever. She has been acting fine otherwise. She has had no vomiting, diarrhea or other constitutional symptoms. She is alert and active in no apparent distress. She is walking in the office without difficulty, although she is whiney. Her left knee has some erythema and swelling, but it is not significantly warm to touch. She also has some swelling of her left foot involving the ankle and the dorsum. It also appears to be getting a little bit of swelling on her right knee with some erythema. Skin: She has an urticarial rash around her umbilicus, axillae, buttocks, trunk and legs. Her nose and mouth is pink and moist. Her lungs are clear to auscultation. Her heart is regular. Her abdomen is soft. Urticaria likely secondary to shots. She also has a contact dermatitis from the bandaid with some vesicles where the band aid was. It appears to be possible serum sickness with swelling of her joints. We will do Benadryl 1 teaspoon PO Q six hours and continue until her rash improves. If she gets sicker, they are to call back and well will consider doing steroids, but I would probably do blood work first.
rash covering areas on thigh size of grapefruit; rash-little raised bumps; (rash @ 4 mos covering areas size of plum following DTP/HIB);
On 09/10/2021 had normal symtoms of body aches, large bruise at injection site and headaches; however on morning of 09/11/2021 I was awaken with temperature on 100.9, body aches, large bruise at injection site , large red area below injection site, light headness, dizziness, equilibrium off and continued to spread and enlarged lymph nodes in right axilla with pain and discomfort.  on 09/13/2021 pt was prescribed Cephalexin 250mg po qid for 10 days, Acetaminophen 50mg po prn, Cetirizine 5mg po prn and Hydrocortisone 0.5% topical cream to use prn.  I followed up with my Primary Care Dr. on 09/14/2021
Within 12 hours of receiving Menactra, pt developed headache, neck pain, spine pain, chills, subjective fever, difficulty standing and walking secondary to pain. Recommended fluids and Ibuprofen. Observed at office visit. Symptoms resolved in 24-48 hours.
- Lightheadedness for 9 days - Rashes / eczema on both arms (never had a rash a day in my life) - Stomach cramps on days 4-6 (and diarrhea)  - Slept all of day 3 - Slept until 1:30 pm on day 4 - Nap on day 5
Site of injection on left leg is red and swollen. Child complains of soreness in leg. There is no fever associated.
6/4 71y.o. male with PMH CAD s/p CABG, PAD s/p BLE stents, COPD presenting for R flank pain. Pt's symptoms developed 2 days ago when he had R flank pain.
Injection was ginve aroound 1:00 Pm on 1/23/21.  Injection site redness was iInitally a small circle  with strong soreness for about 3 days.  There was firmness under the skin at the injection site also.  On or about 1/31 in the am, I noticed the redness was getting larger and has expanced to a oblong area about 6-7 inches in length.  The area is not real sore but is somewhat hot.  Spke with my primary care today and she has prescribed me to take Benedryal and use cold compress on the area for now.  If now better in 2 to 3 days.to go back and see her.  I am scheduled for my 2nd shot on 2/20/21.
Mild fever; chills; body aches; headache; dizzy; slight cough; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 22Apr2021 at 10:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history included sinus tachycardia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) 25 mg and cannabis sativa (CBD BROAD SPECTRUM TICNTURE) 1200mg; both for unspecified indication and start date. The patient previously took cefdinir (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 01Apr2021 at 10:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 17:00, the patient experienced mild fever, chills, body aches, headache, dizzy, slight cough. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild fever, chills, body aches, headache, dizzy, slight cough was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
High dose flu given to 3 year old inadvertently.  No s/s at time of call to mother.
April 26 2021 10:00 pm onset of noticeable chills 11:00 pm onset of severe chills, difficulty handling cutlery and other small household items precisely  April 27 2021 01:00 am woke up with severe headache and neck pain, dehydration, dry mouth, general soreness body wide. Chills were gone by 01:00 am 01:30 am-03:00 am moderate fever, burning up 03:00 am onset of mild nausea, difficulty drinking water to rehydrate 03:30 am onset of severe nausea, unable to drink water or ginger ale. headache subsides to moderate 05:45 am vomited 06:00 am nausea subsides to mild, again able to drink some water and ginger ale. neck soreness mild, rest of body back to normal 01:00 pm headache has subsided to mild and nausea is mostly gone 03:00 pm headache mostly gone, but recurs when standing up or sitting down quickly 08:00 pm mostly back to normal. mild lingering neck soreness  In addition, pain at injection site (left deltoid) prevented me from raising my arm above my shoulder from April 26 ~8:00 pm to April 28 ~8 am.  Symptoms other than feeling jet lagged were over by the time I woke up again the next day (8:20 am April 28)  Light to mild pain using my left arm persisted until the morning of April 29.
Most severe symptoms was injection site soreness initially, followed by overall myalgias, chills, and fatigue. Recovered in 2 days.
Low grade fever and fatigue started around 7:30pm followed by severe chills. Woke up the next morning around 8am with headache that went away after a couple hours. Felt great the rest of the day with slight soreness at the injection site.
hectic Tinnitus; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (hectic Tinnitus) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced TINNITUS (hectic Tinnitus). At the time of the report, TINNITUS (hectic Tinnitus) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-092173 (Patient Link).
shingles; shortness of breath and cough/chronic obstructive pulmonary disease exacerbation; shortness of breath and cough/pneumonia; vertigo; Information has been received from a lawyer concerning a case in litigation and refers to a female patient of an unknown age. No information has been received about the patient's medical history, concurrent conditions and concomitant medications. On 09-OCT-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) vaccine (dose, route of administration, lot #, expiry date and vaccination site were not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered shortness of breath and cough. The patient was hospitalized and diagnosed with chronic obstructive pulmonary disease exacerbation, pneumonia, vertigo and herpes zoster. As a direct and proximate result of the Company's defective zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the Company's product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was not recovered. The causality was related.  The events of chronic obstructive pulmonary disease exacerbation, pneumonia, vertigo and herpes zoster were considered to be disabling. Upon internal review, the event of pneumonia was determined to be medically significant.
run a high fever; Initial information received on 26-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer from social media report.  This case involves a unknown demographic patient who experienced run a high fever (pyrexia), while the received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date in 2019, the patient developed a non-serious run a high fever (pyrexia) (Unknown latency) more take patient's Vit following the administration of INFLUENZA VACCINE.  No laboratory data was provided.  Final diagnosis was run a high pyrexia.   It was not reported if the patient received a corrective treatment.  The outcome was reported as Unknown for run a high fever.
Fever or Chills  Fatigue  Muscle or body aches  Headache  Sore throat Patient is a 48-year-old female presenting today for evaluation of respiratory symptoms that started about 5 days ago.  She notes that her husband tested positive for COVID-19 yesterday.  She has been having rhinorrhea, congestion, headache, postnasal drainage, cough and sore throat.  No fevers or vomiting or diarrhea.  She has been taking Tylenol intermittently.  She denies a history of asthma but does have a history of frequent bronchitis.  She is a non-smoker.  She is Covid vaccinated.
Elevated Heart Rate, BP, followed by vertigo and muscle weakness.  Started about 23:30 2/26/21 and lasted until 2/27/21 16:00. After that just  nausea and tiredness for 3 days.
swelling of the left arm redness of left arm painful to move left arm  apply ice to the left arm area, take Aleve as directed after food. if worsening follow up in the clinic.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 2 days after receiving SHINGRIX, the patient experienced rash. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional information was received as follows: The age at vaccination was not reported. The reporting pharmacy intern stated that the patient experienced rash 2 to 3 days after vaccination with SHINGRIX. The reporter stated that she had no other information and that she spoke to the patient very briefly over the phone.
31DEC98 pt recv vax & states that 30DEC98 pt woke up w/fever;states redness & swelling w/blisters @ inj site;states lt side of face w/blisters & redness;states no SOB;pt not seen by MD but seen by nurse;
No adverse event; injected the Moderna booster accidentally; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (injected the Moderna booster accidentally) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 015H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer vaccine (Dose 4) on 12-Apr-2022, Pfizer vaccine (Dose 2), Pfizer vaccine (Dose 1) and Pfizer vaccine (Dose 3). Past adverse reactions to the above products included No adverse event with Pfizer vaccine, Pfizer vaccine, Pfizer vaccine and Pfizer vaccine.    On 06-Nov-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 06-Nov-2022, the patient experienced WRONG PRODUCT ADMINISTERED (injected the Moderna booster accidentally). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (injected the Moderna booster accidentally) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
On 3/10/2021 around 2 pm reported more fatigue, low-grade fever, and weak; treated w/ Tylenol; 3/13/2021 refused medications; 3/16/2021 became constipated; 3/20/2021 gait unsteady and reported feeling as though she'd fall; more fatigued; 3/20/2021 refused medications and slept excessively; 3/20/21 vomited in bed; 3/22/2021 restless and exit seeking; 3/25/2021 packed belongings and exhibited exit seeking; 3/26/2021 transported to hospital 5:15 am due to falling while attempting to pick up something off of the floor; 3/29/2021 hospital reported she had a brain bleed and had chosen hospice care at her daughter's home; resident passed away on 3/30/2021.
Erythematous rash with slight edema and tenderness to  palpation lasting about 3-4 days. Rash began about 1 day after 2nd injection.